[go: up one dir, main page]

PT1928875E - 2-amino-7,8-di-hidro-6h-pirido[4,3-d]pirimidin-5-onas - Google Patents

2-amino-7,8-di-hidro-6h-pirido[4,3-d]pirimidin-5-onas Download PDF

Info

Publication number
PT1928875E
PT1928875E PT06825272T PT06825272T PT1928875E PT 1928875 E PT1928875 E PT 1928875E PT 06825272 T PT06825272 T PT 06825272T PT 06825272 T PT06825272 T PT 06825272T PT 1928875 E PT1928875 E PT 1928875E
Authority
PT
Portugal
Prior art keywords
pyrido
pyrimidin
dihydro
ones
amino
Prior art date
Application number
PT06825272T
Other languages
English (en)
Inventor
Daniel Poon
Teresa Pick
Timothy D Machajewski
Cynthia M Shafer
Christopher Mcbride
William Antonios-Mccrea
Brandon M Doughan
Barry H Levine
Yi Xia
Maureen Mckenna
X Michael Wang
Kris Mendenhall
Yasheen Zhou
Baoqing Gong
Dan Gu
John Dolan
John Tulinsky
Kristin Brinner
Zhenhai Gao
Paul A Renhowe
Paul A Barsanti
Xiaodong Lin
Abran Costales
Nathan Brammeier
Alice Rico
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT1928875E publication Critical patent/PT1928875E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT06825272T 2005-09-30 2006-09-28 2-amino-7,8-di-hidro-6h-pirido[4,3-d]pirimidin-5-onas PT1928875E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72279605P 2005-09-30 2005-09-30
US83688606P 2006-08-09 2006-08-09

Publications (1)

Publication Number Publication Date
PT1928875E true PT1928875E (pt) 2011-09-06

Family

ID=37661234

Family Applications (1)

Application Number Title Priority Date Filing Date
PT06825272T PT1928875E (pt) 2005-09-30 2006-09-28 2-amino-7,8-di-hidro-6h-pirido[4,3-d]pirimidin-5-onas

Country Status (31)

Country Link
US (2) US7671059B2 (pt)
EP (1) EP1928875B1 (pt)
JP (2) JP5036002B2 (pt)
KR (1) KR101311757B1 (pt)
AR (1) AR058072A1 (pt)
AT (1) ATE514694T1 (pt)
AU (1) AU2006297124B2 (pt)
BR (1) BRPI0616701A2 (pt)
CA (1) CA2624253C (pt)
CR (1) CR9846A (pt)
CY (1) CY1112028T1 (pt)
DK (1) DK1928875T3 (pt)
EA (1) EA016152B1 (pt)
EC (1) ECSP088324A (pt)
GE (1) GEP20115231B (pt)
HR (1) HRP20110655T1 (pt)
IL (1) IL190446A0 (pt)
JO (1) JO2783B1 (pt)
MA (1) MA29885B1 (pt)
ME (1) ME01952B (pt)
MY (1) MY143604A (pt)
NO (1) NO342258B1 (pt)
NZ (1) NZ566914A (pt)
PE (1) PE20070621A1 (pt)
PL (1) PL1928875T3 (pt)
PT (1) PT1928875E (pt)
RS (1) RS51795B (pt)
SM (1) SMAP200800029A (pt)
TN (1) TNSN08143A1 (pt)
TW (1) TWI373471B (pt)
WO (1) WO2007041362A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007002994A1 (es) * 2006-10-19 2008-02-08 Wyeth Corp Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
CN101225083A (zh) * 2007-01-16 2008-07-23 北京摩力克科技有限公司 四氢喹唑啉酮类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
GB2449293A (en) * 2007-05-17 2008-11-19 Evotec Compounds having Hsp90 inhibitory activity
SG187502A1 (en) * 2008-02-01 2013-02-28 Takeda Pharmaceutical Oxim derivatives as hsp90 inhibitors
CA2737948A1 (en) * 2008-09-26 2010-04-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Host cell kinases as targets for antiviral therapies against hcv infection
RU2011126254A (ru) 2008-11-28 2013-01-10 Новартис Аг Применение ингибтиторов hsp90 для терапевтического лечения
KR20170113683A (ko) * 2008-11-28 2017-10-12 노파르티스 아게 피리도〔4,3-ｄ〕피리미딘 유래의 ｈｓｐ90-억제제 및 ｈｅｒ2 억제제를 포함하는 제약 조합물
BRPI0922301A2 (pt) * 2008-11-28 2019-02-26 Novartis Ag combinações de inibidor de hsp90
AR075180A1 (es) 2009-01-29 2011-03-16 Novartis Ag Formulaciones orales solidas de una pirido-pirimidinona
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr) 2009-09-03 2011-11-25 Sanofi Aventis Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
EP2493313B1 (en) * 2009-10-29 2017-12-13 Genosco Kinase inhibitors
WO2012104823A2 (en) 2011-02-04 2012-08-09 Novartis Ag Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases
EP2766015A1 (en) 2011-10-14 2014-08-20 Novartis AG 2-carboxamide cycloamino urea derivatives in combination with hsp90 inhibitors for the treatment of proliferative diseases
ITTO20111013A1 (it) 2011-11-03 2013-05-04 Dac Srl Composti farmaceutici
CN103664938A (zh) * 2012-09-12 2014-03-26 山东亨利医药科技有限责任公司 含有嘧啶并环的syk抑制剂
WO2014074580A1 (en) 2012-11-07 2014-05-15 Novartis Ag Combination therapy
US9677907B2 (en) * 2013-03-14 2017-06-13 Itron Inc Intelligent receptacle
GB201306610D0 (en) * 2013-04-11 2013-05-29 Almac Discovery Ltd Pharmaceutical compounds
KR101767859B1 (ko) * 2013-09-30 2017-08-11 다이호야쿠힌고교 가부시키가이샤 아자 2 고리형 화합물을 사용한 암 병용 요법
WO2016034642A1 (en) * 2014-09-02 2016-03-10 Pierre Fabre Medicament Isoquinolinone derivatives useful in the treatment of cancer
KR20160035411A (ko) * 2014-09-23 2016-03-31 주식회사 오스코텍 LRRK2 (Leucine Rich Repeat Kinase 2) 키나제 억제제로서의 피리도피리미딘 유도체 화합물
KR101653560B1 (ko) * 2016-02-02 2016-09-12 한국화학연구원 신규한 화합물 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 함유하는 인플루엔자 바이러스 감염으로 인한 질환의 예방 또는 치료용 약학적 조성물
RU2629599C1 (ru) * 2016-09-28 2017-08-30 Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) Способ химиолучевого лечения опухолей прямой кишки и анального канала
CN110799520B (zh) 2017-06-09 2024-07-12 中外制药株式会社 用于合成含有n-取代氨基酸的肽的方法
EP4174056A4 (en) * 2020-06-26 2024-08-07 Nihon Nohyaku Co., Ltd. ARYLTETRAHYDROPYRIDINE DERIVATIVE OR SALT THEREOF, INSECTICIDE THEREOF AND METHOD OF USE THEREOF
AU2022234998B2 (en) * 2021-03-08 2025-04-10 Jinan University Pyridopyrimidine compounds and applications thereof
WO2026027375A1 (de) 2024-07-29 2026-02-05 Bayer Aktiengesellschaft Hydroxy-dihydropyridinon carboxamide als schädlingsbekämpfungsmittel

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6165873A (ja) 1984-09-07 1986-04-04 Mitsui Petrochem Ind Ltd ２−ピペラジノピリミジン誘導体
CA1307786C (en) 1984-12-14 1992-09-22 Keiichi Yokoyama Quinazoline derivatives and antihypertensive preparations containing same as effective components
IL85347A0 (en) 1987-02-11 1988-07-31 May & Baker Ltd Cyclic diones
WO2002064594A2 (en) * 2001-02-12 2002-08-22 F. Hoffmann-La Roche Ag 6-substituted pyrido-pyrimidines
DE102004018198A1 (de) 2004-04-15 2005-11-03 Merck Patent Gmbh Sulfonamide
EP2332527A3 (en) 2004-10-20 2011-11-16 Resverlogix Corp. Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases
US20100152206A1 (en) * 2005-01-07 2010-06-17 Ralph Mazitschek Bicyclic Dihydropyrimidines and Uses Thereof
CA2604942A1 (en) 2005-04-14 2006-10-26 Novartis Vaccines And Diagnostics, Inc. 2-amino-quinaz0lin-5-ones

Also Published As

Publication number Publication date
TNSN08143A1 (en) 2009-07-14
KR20080057318A (ko) 2008-06-24
WO2007041362A1 (en) 2007-04-12
NZ566914A (en) 2011-09-30
CR9846A (es) 2008-08-01
RS51795B (sr) 2011-12-31
TWI373471B (en) 2012-10-01
JP2009510108A (ja) 2009-03-12
HRP20110655T1 (hr) 2011-10-31
JP5036002B2 (ja) 2012-09-26
HK1118823A1 (en) 2009-02-20
TW200728304A (en) 2007-08-01
EP1928875B1 (en) 2011-06-29
IL190446A0 (en) 2008-11-03
ATE514694T1 (de) 2011-07-15
JO2783B1 (en) 2014-03-15
ME01952B (en) 2011-12-31
NO342258B1 (no) 2018-04-30
EA200800992A1 (ru) 2008-10-30
CA2624253C (en) 2015-06-16
NO20082069L (no) 2008-06-09
DK1928875T3 (da) 2011-10-03
US20070123546A1 (en) 2007-05-31
SMP200800029B (it) 2008-05-07
AU2006297124B2 (en) 2011-12-08
JP2012158611A (ja) 2012-08-23
SMAP200800029A (it) 2008-05-07
AR058072A1 (es) 2008-01-23
CY1112028T1 (el) 2015-11-04
EP1928875A1 (en) 2008-06-11
US20100004237A1 (en) 2010-01-07
MY143604A (en) 2011-06-15
ECSP088324A (es) 2008-04-28
KR101311757B1 (ko) 2013-09-26
CA2624253A1 (en) 2007-04-12
US7671059B2 (en) 2010-03-02
MA29885B1 (fr) 2008-10-03
GEP20115231B (en) 2011-06-10
EA016152B1 (ru) 2012-02-28
PE20070621A1 (es) 2007-09-06
AU2006297124A1 (en) 2007-04-12
BRPI0616701A2 (pt) 2011-06-28
PL1928875T3 (pl) 2011-11-30

Similar Documents

Publication Publication Date Title
PL1928875T3 (pl) 2-Amino-7,8-dihydro-6H-pirydo(4,3-d)pirymidyn-5-ony, sposoby ich otrzymywania oraz kompozycje farmaceutyczne je zawierające
IL185353A0 (en) Azabicycloalkane derivatives , pharmaceutical compositions containing the same and methods for the preparation thereof
IL188050A (en) The history of azaindazole, their medicinal preparations and their uses
IL193141A (en) Compounds including pyrrolo [2,3– d] pyrimidine 7 - yl and sulphamate, pharmaceuticals and their use
IL189737A0 (en) Pyrazine derivatives, their preparation and pharmaceutical compositions containing them
IL184783A0 (en) Aminopyridine derivatives and pharmaceutical compositions containing the same
IL182121A0 (en) Pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containingthe same
IL225207A (en) A derivative of multi-ring carbamoylpyridone, its pharmaceutical composition, its use and its preparation
IL169500A0 (en) Pyrrolopyridazine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL193772A0 (en) 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same
IL181618A0 (en) Pharmaceutical solid-in-oil compositions for external administraton, methods for preparation and uses thereof
IL189782A (en) The history of sulfonylpyrol and its medicinal products and their use
IL200695A (en) History of Hydro-Oxazolo [2,3-a] Pyrimidine-7-Wen and Pharmaceutical Preparations Containing Them
IL198509A0 (en) Azaindole derivatives, compositions containing the same and uses thereof
PL2036892T3 (pl) Pochodne 1,2,4,5-tetrahydro-3H-benzazepin, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne
IL181022A0 (en) Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same
HUP0401522A2 (en) New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
PL1720544T3 (pl) Nowe pochodne azabicykliczne, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne
IL186062A (en) Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
TWI315305B (en) Piperidin-4-yl-amide derivatives,pharmaceutical compositions comprising the same,process for preparing the same and the use thereof
ZA200803658B (en) 2-amino-7,8-dihydro-6H-pyrido[4,3-d] pyrimidin-5-ones
EP1916251A4 (en) ERIANINE SALTS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IL188773A0 (en) Benzimidazoles and imidazopyridine derivatives and pharmaceutical compositions containing the same
ZA200806399B (en) Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
IL175724A0 (en) Tricyclic imidazopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same